JP2025013344A5 - - Google Patents

Info

Publication number
JP2025013344A5
JP2025013344A5 JP2024173357A JP2024173357A JP2025013344A5 JP 2025013344 A5 JP2025013344 A5 JP 2025013344A5 JP 2024173357 A JP2024173357 A JP 2024173357A JP 2024173357 A JP2024173357 A JP 2024173357A JP 2025013344 A5 JP2025013344 A5 JP 2025013344A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
formula
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024173357A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025013344A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/016925 external-priority patent/WO2020163554A1/en
Priority claimed from PCT/US2020/050924 external-priority patent/WO2021055376A1/en
Application filed filed Critical
Publication of JP2025013344A publication Critical patent/JP2025013344A/ja
Publication of JP2025013344A5 publication Critical patent/JP2025013344A5/ja
Pending legal-status Critical Current

Links

JP2024173357A 2019-09-16 2024-10-02 Il-17aモジュレーターおよびその使用 Pending JP2025013344A (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201962901249P 2019-09-16 2019-09-16
US62/901,249 2019-09-16
PCT/US2020/016925 WO2020163554A1 (en) 2019-02-06 2020-02-06 Il-17a modulators and uses thereof
US16/783,268 US11447468B2 (en) 2019-02-06 2020-02-06 IL-17 ligands and uses thereof
US16/783,268 2020-02-06
USPCT/US2020/016925 2020-02-06
US202063061719P 2020-08-05 2020-08-05
US63/061,719 2020-08-05
PCT/US2020/050924 WO2021055376A1 (en) 2019-09-16 2020-09-15 Il-17a modulators and uses thereof
JP2022516442A JP7566889B2 (ja) 2019-09-16 2020-09-15 Il-17aモジュレーターおよびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022516442A Division JP7566889B2 (ja) 2019-09-16 2020-09-15 Il-17aモジュレーターおよびその使用

Publications (2)

Publication Number Publication Date
JP2025013344A JP2025013344A (ja) 2025-01-24
JP2025013344A5 true JP2025013344A5 (https=) 2025-10-15

Family

ID=74884681

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022516442A Active JP7566889B2 (ja) 2019-09-16 2020-09-15 Il-17aモジュレーターおよびその使用
JP2024173357A Pending JP2025013344A (ja) 2019-09-16 2024-10-02 Il-17aモジュレーターおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022516442A Active JP7566889B2 (ja) 2019-09-16 2020-09-15 Il-17aモジュレーターおよびその使用

Country Status (12)

Country Link
US (4) US11274094B2 (https=)
EP (1) EP4031534A1 (https=)
JP (2) JP7566889B2 (https=)
KR (1) KR20220101075A (https=)
CN (1) CN115103835B (https=)
AU (2) AU2020348685B2 (https=)
BR (1) BR112022004802A2 (https=)
CA (1) CA3154608A1 (https=)
IL (1) IL291345B2 (https=)
MX (1) MX2022003166A (https=)
WO (1) WO2021055376A1 (https=)
ZA (1) ZA202203580B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113874080B (zh) 2019-02-06 2024-09-27 戴斯阿尔法公司 Il-17a调节剂及其用途
EP4031534A1 (en) 2019-09-16 2022-07-27 Dice Alpha, Inc. Il-17a modulators and uses thereof
MX2024000504A (es) * 2021-07-09 2024-04-05 Dice Alpha Inc Moduladores de il-17a basados en fenilacetamida y usos de los mismos.
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
CN113896712B (zh) * 2021-11-12 2024-04-09 华东理工大学 含环类氨基酸的二酰胺类化合物
WO2023111181A1 (en) 2021-12-16 2023-06-22 Leo Pharma A/S Small molecule modulators of il-17
KR20240157703A (ko) * 2022-02-25 2024-11-01 다이스 알파, 인크. 디-시클로프로필 기재 il-17a 조정제 및 그의 용도
WO2023166172A1 (en) 2022-03-04 2023-09-07 Leo Pharma A/S Small molecule modulators of il-17
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024208228A1 (en) * 2023-04-03 2024-10-10 Nuphase Therapeutics (Hangzhou) Limited., Co. Novel compounds, compositions comprising the same and uses thereof
EP4711365A1 (en) * 2023-05-12 2026-03-18 Shanghai Hansoh Biomedical Co., Ltd. Thiazole derivative inhibitor, and preparation method therefor and use thereof
CN121219278A (zh) * 2023-05-18 2025-12-26 歌礼制药(中国)有限公司 Il-17a的小分子调节剂、其制备方法和使用方法
WO2025077732A1 (en) * 2023-10-09 2025-04-17 Shenzhen Ionova Life Science Co., Ltd. Novel interleukin-17 inhibtors
WO2025080986A1 (en) * 2023-10-13 2025-04-17 Quantx Biosciences Us, Inc. Amide compounds
TW202542125A (zh) * 2023-12-21 2025-11-01 大陸商江蘇恆瑞醫藥股份有限公司 烯烴類化合物、其製備方法及其在醫藥上的應用
WO2025201533A1 (en) * 2024-03-28 2025-10-02 Nuphase Therapeutics (Shanghai) Limited., Co. Novel acidic compounds, compositions comprising the same and uses thereof
WO2025201532A1 (en) * 2024-03-28 2025-10-02 Nuphase Therapeutics (Shanghai) Limited., Co. Novel pegylation compounds, compositions comprising the same and uses thereof
WO2025209397A1 (en) * 2024-04-03 2025-10-09 Innocare Pharma Inc. Il-17 modulators and used thereof
CN121405690A (zh) * 2024-07-24 2026-01-27 深圳信立泰药业股份有限公司 双环il-17a/f抑制剂及其制备方法与应用
WO2026040422A1 (en) * 2024-08-19 2026-02-26 Shenzhen Ionova Life Science Co., Ltd. Novel interleukin-17 inhibtors
WO2026077367A1 (en) * 2024-10-09 2026-04-16 Foshan Ionova Biotherapeutics Co., Inc. Novel interleukin-17 inhibtors

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
GB1429184A (en) 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
USRE28819E (en) 1972-12-08 1976-05-18 Syntex (U.S.A.) Inc. Dialkylated glycol compositions and medicament preparations containing same
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4358603A (en) 1981-04-16 1982-11-09 Syntex (U.S.A.) Inc. Acetal stabilized prostaglandin compositions
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
HU196714B (en) 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
PH30995A (en) 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5543390A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
US6024975A (en) 1992-04-08 2000-02-15 Americare International Diagnostics, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6004534A (en) 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5759542A (en) 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5983134A (en) 1995-04-23 1999-11-09 Electromagnetic Bracing Systems Inc. Electrophoretic cuff apparatus drug delivery system
US6316652B1 (en) 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
AU6242096A (en) 1995-06-27 1997-01-30 Takeda Chemical Industries Ltd. Method of producing sustained-release preparation
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
TW448055B (en) 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
JP2909418B2 (ja) 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
US6039975A (en) 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
US5980945A (en) 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
TW345603B (en) 1996-05-29 1998-11-21 Gmundner Fertigteile Gmbh A noise control device for tracks
US6264970B1 (en) 1996-06-26 2001-07-24 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6419961B1 (en) 1996-08-29 2002-07-16 Takeda Chemical Industries, Ltd. Sustained release microcapsules of a bioactive substance and a biodegradable polymer
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
JP2000508339A (ja) 1996-10-01 2000-07-04 シーマ・ラブス・インコーポレイテッド 味隠蔽マイクロカプセル組成物及び製造方法
CA2217134A1 (en) 1996-10-09 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Sustained release formulation
PT839525E (pt) 1996-10-31 2004-10-29 Takeda Chemical Industries Ltd Preparacao de libertacao prolongada
US6131570A (en) 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
WO1998027980A2 (en) 1996-12-20 1998-07-02 Takeda Chemical Industries, Ltd. Method of producing a sustained-release preparation
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US5860957A (en) 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
CN1152673C (zh) 1997-10-28 2004-06-09 坂东化学株式会社 皮肤贴附药片及其基片的制造方法
TR200002059T2 (tr) 1998-01-16 2001-01-22 Takeda Chemical Industries, Ltd. Devamlı salınan bileşim, üretim yöntemi ve kullanımı.
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US6048736A (en) 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
KR19990085365A (ko) 1998-05-16 1999-12-06 허영섭 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6261595B1 (en) 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
JP2007501775A (ja) 2003-08-07 2007-02-01 ノバルティス アクチエンゲゼルシャフト 免疫抑制剤としてのヒストンデアセチラーゼ阻害剤
JP2007505136A (ja) 2003-09-10 2007-03-08 マツプ・フアーマシユーテイカルズ・インコーポレーテツド ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
TWI541021B (zh) * 2009-03-05 2016-07-11 艾伯維有限公司 Il-17結合蛋白
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17
WO2014066726A2 (en) * 2012-10-26 2014-05-01 Ensemble Therapeutics Corporation Compounds for modulating il-17
EP3018123B1 (en) * 2013-07-03 2023-05-10 Takeda Pharmaceutical Company Limited Amide compound
WO2015082533A1 (en) * 2013-12-05 2015-06-11 Lead Pharma Cel Models Ip B.V. Ror gamma (rory) modulators
EP3101006A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
WO2018030550A1 (en) * 2016-08-09 2018-02-15 Takeda Pharmaceutical Company Limited Heterocyclic compounds with an ror(gamma)t modulating activity
EP3523279A1 (en) * 2016-10-10 2019-08-14 Bristol-Myers Squibb Company Tricyclic sulfones as ror gamma modulators
AU2019224354A1 (en) * 2018-02-22 2020-10-08 Nippon Zoki Pharmaceutical Co., Ltd. IL-17a activity inhibitor and use thereof
GB201820166D0 (en) 2018-12-11 2019-01-23 Ucb Biopharma Sprl Therapeutic agents
CN113874080B (zh) * 2019-02-06 2024-09-27 戴斯阿尔法公司 Il-17a调节剂及其用途
EP4031534A1 (en) 2019-09-16 2022-07-27 Dice Alpha, Inc. Il-17a modulators and uses thereof

Similar Documents

Publication Publication Date Title
JP2025013344A5 (https=)
JP2024071370A5 (https=)
JP2021063088A5 (https=)
JP2023002662A5 (https=)
JP2023098946A5 (https=)
JP2024538705A5 (https=)
JPWO2023027198A5 (https=)
JP2012502037A5 (https=)
JP2010512413A5 (https=)
JP2022191257A5 (https=)
JP2004526788A5 (https=)
JP2024540183A5 (https=)
JP2009500443A5 (https=)
JP2010077141A5 (https=)
JP2005537268A5 (https=)
JP2025161856A5 (https=)
JP2018531273A5 (https=)
JP2022552881A5 (https=)
JP2014521641A5 (https=)
JP2021530554A5 (https=)
JP2019218379A5 (https=)
JP2019151627A5 (https=)
JP2025502064A5 (https=)
JP2012510985A5 (https=)
JP2025163212A5 (https=)